Pabco 85% Magnesia Insulating Cement

Product Description

Pabco 85% Magnesia Insulating Cement was an industrial thermal insulation product manufactured by Fibreboard Corporation under the Pabco product line. The cement was formulated primarily from magnesium carbonate—the mineral compound that gives the product its “85% magnesia” designation—and was engineered to resist high-temperature industrial environments where conventional insulation materials would fail or degrade rapidly.

Products in the 85% magnesia category were a standard of industrial insulation practice throughout much of the twentieth century. They were applied as a trowelable or packable cement to pipe systems, boilers, pressure vessels, tanks, and other equipment operating at elevated temperatures. The finished product could be shaped by hand or tool around irregular surfaces, allowed to cure, and then typically covered with an outer finishing layer or jacketing material. This versatility made 85% magnesia cements a preferred material in power generation, chemical processing, petroleum refining, shipbuilding, and heavy manufacturing.

Fibreboard sold Pabco-branded products across a wide range of industrial insulation applications, and the 85% Magnesia Insulating Cement represented one of the company’s entries into the high-temperature pipe and equipment insulation market. These products were distributed through industrial supply channels and installed across facilities throughout the United States.

Asbestos Content

Magnesia insulating cements in the 85% magnesia category commonly incorporated asbestos fibers as a reinforcing and binding agent during a significant portion of the twentieth century. Asbestos—particularly chrysotile and, in some formulations, amphibole varieties—was added to improve tensile strength, reduce cracking during application and cure, and enhance the product’s ability to withstand thermal cycling and mechanical stress in service.

The asbestos component in these cements served a functional purpose: without a fibrous reinforcing material, the dried magnesia matrix could become brittle and prone to fracture under the vibration and temperature fluctuation characteristic of industrial piping systems. Asbestos fibers distributed throughout the cement matrix helped hold the cured material together and extend service life.

Litigation records document that plaintiffs alleged Pabco 85% Magnesia Insulating Cement contained asbestos as a component of its formulation and that this asbestos was capable of releasing respirable fibers during the product’s normal use and maintenance lifecycle. While exact fiber type and percentage concentrations by weight have been addressed through discovery in individual cases, Fibreboard’s broader product line history has been extensively examined in asbestos litigation, and the company’s magnesia cement products have been identified in numerous claims.

How Workers Were Exposed

Exposure to asbestos from Pabco 85% Magnesia Insulating Cement primarily affected industrial workers who handled, applied, disturbed, or worked in proximity to the material. The product’s use profile meant that exposure was not limited to a single occupation or trade but extended to a broad category of workers across industrial sectors.

Application and installation presented direct, hands-on exposure. Workers mixing the cement from dry powder or packaged forms, troweling it onto pipe surfaces, and shaping it around fittings and valves would have handled material that could release asbestos-containing dust during mixing, blending, and wet or dry manipulation.

Cutting, sawing, and fitting operations created additional exposure pathways. When the cured cement had to be trimmed or shaped to fit around complex pipe configurations—or when old insulation had to be removed before new material was applied—the mechanical disturbance of dried magnesia cement could release significant quantities of airborne asbestos fibers.

Maintenance and repair activities were particularly significant. Industrial insulation is routinely disturbed during equipment inspection, repair, and overhaul cycles. Workers who broke away or chipped off old cement to access pipe joints, valves, or equipment flanges would encounter friable, degraded material that could release asbestos fibers into the breathing zone.

Bystander exposure affected industrial workers generally—a category that litigation records document as central to many Pabco-related claims. In industrial facilities such as refineries, power plants, and manufacturing plants, workers in trades unrelated to insulation could be present in the same work areas where insulation work was being performed. Machinists, pipefitters, operators, electricians, and general laborers could inhale asbestos fibers released by nearby insulation work without ever directly touching the product.

Plaintiffs alleged that the nature of industrial work environments made complete separation between insulation workers and general industrial workers functionally impossible, and that Fibreboard and similar manufacturers knew or should have known that their products created hazardous exposure conditions for all workers present in those environments.

The latency period for asbestos-related disease—typically ranging from ten to fifty years between exposure and diagnosis—means that workers exposed to Pabco 85% Magnesia Insulating Cement during peak use decades may only now be receiving diagnoses of mesothelioma, asbestosis, lung cancer, or other asbestos-related conditions.

Documented Trust Fund / Legal Options

Fibreboard Corporation faced extensive asbestos litigation related to its Pabco and other product lines. The volume of claims against the company ultimately contributed to resolution through the Fibreboard bankruptcy and claims resolution process. The Fibreboard Asbestos Trust was established as part of this process to resolve pending and future asbestos claims against the company.

Individuals who were exposed to Pabco products, including Pabco 85% Magnesia Insulating Cement, and who have received a qualifying diagnosis may be eligible to file a claim with the Fibreboard Asbestos Trust. Trust claims are evaluated based on established medical and exposure criteria, and claimants are generally required to demonstrate:

• A qualifying asbestos-related diagnosis (mesothelioma, lung cancer, asbestosis, or other recognized conditions)
• Documented or reasonably supported exposure to a Fibreboard product
• Exposure during a covered period consistent with the product’s period of manufacture and distribution

Typical claim categories recognized by asbestos trusts include mesothelioma claims, lung cancer claims with qualifying exposure history, and non-malignant disease claims such as asbestosis and pleural disease. Mesothelioma claims generally receive expedited review and higher compensation values given the severity and rarity of the disease.

Beyond the Fibreboard Trust, individuals may have claims against multiple parties. Because Pabco 85% Magnesia Insulating Cement was used alongside products from many other manufacturers in industrial facilities, workers were often exposed to asbestos from numerous sources. Other manufacturers, product suppliers, facility owners, and contractors may bear legal responsibility, and surviving trusts or ongoing litigation may provide additional avenues for recovery.

Anyone diagnosed with mesothelioma or another asbestos-related illness who believes they had exposure to Pabco 85% Magnesia Insulating Cement should consult with an attorney experienced in asbestos litigation to evaluate their full range of potential claims. Documentation of work history, facility locations, and any available employment or union records can be valuable in supporting both trust fund filings and litigation claims.